Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.
Funding Rounds (3) - $50MUpdate
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
Mission Bay Capital, LLC, is an independent seed-stage venture firm focused on making pivotal,...
Health-Care Focused VC Firm
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life...
Since 1974, Sofinnova Ventures has partnered with entrepreneurs to secure initial funding, build...
400 East Jamie Court
South San Francisco, CA 94080